Papers: 10.1186/s13075-016-0985-2
https://doi.org/10.1186/s13075-016-0985-2
Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)
Cited by: 3
Author(s): Ruediger B Mueller, Michael Gengenbacher, Symi Richter, Jean Dudler, Burkhard Möller, Johannes von Kempis
Published: over 10 years ago
Software Mentions 2
Very Likely Science (75)
Very Likely Science (100)